EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C8H13NO2 |
| Net Charge | 0 |
| Average Mass | 155.197 |
| Monoisotopic Mass | 155.09463 |
| SMILES | COC(=O)C1=CCCN(C)C1 |
| InChI | InChI=1S/C8H13NO2/c1-9-5-3-4-7(6-9)8(10)11-2/h4H,3,5-6H2,1-2H3 |
| InChIKey | HJJPJSXJAXAIPN-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | muscarinic agonist Any drug that binds to and activates a muscarinic cholinergic receptor. metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
| Application: | muscarinic agonist Any drug that binds to and activates a muscarinic cholinergic receptor. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| arecoline (CHEBI:2814) has role metabolite (CHEBI:25212) |
| arecoline (CHEBI:2814) has role muscarinic agonist (CHEBI:38325) |
| arecoline (CHEBI:2814) is a enoate ester (CHEBI:51702) |
| arecoline (CHEBI:2814) is a methyl ester (CHEBI:25248) |
| arecoline (CHEBI:2814) is a pyridine alkaloid (CHEBI:26416) |
| arecoline (CHEBI:2814) is a tetrahydropyridine (CHEBI:26921) |
| IUPAC Name |
|---|
| methyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate |
| Synonyms | Source |
|---|---|
| arecaidine methyl ester | ChEBI |
| arecaline | ChEBI |
| arecholine | ChEBI |
| arekolin | ChEBI |
| methylarecaiden | ChEBI |
| methylarecaidin | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| Arecoline | Wikipedia |
| C00002020 | KNApSAcK |
| C10129 | KEGG COMPOUND |
| CN101411705 | Patent |
| CN102464607 | Patent |
| DB04365 | DrugBank |
| HMDB0030353 | HMDB |
| LSM-15214 | LINCS |
| US2506458 | Patent |
| Registry Numbers | Sources |
|---|---|
| Reaxys:123045 | Reaxys |
| CAS:63-75-2 | KEGG COMPOUND |
| CAS:63-75-2 | ChemIDplus |
| Citations |
|---|